About this trial
The goal of this crossover clinical trial is to explore the effects of red meat intake on serum and fractional urinary excretion of uremic toxins including trimethylamine N-oxide in people with chronic kidney disease.
Eligibility criteria
Qualifiers
Age 40-70 years
Male or postmenopausal female
Stage 3 CKD (eGFR between 30-59ml/min/1.73m² by the CKD-EPI equation (without race correction)).
If eGFR is greater than or equal to 45ml/min/1.73m² then albuminuria must be greater than 300mg/g creatinine by spot urine.
Disqualifiers
Hemoglobin A1c greater than 7% within previous six months
Treatment with metformin or insulin within previous three months
Blood pressure greater than 150/100 mmHg from chart of home on at least two occasions in prior month (can be inclusive of screening visit)
Change in cardiovascular and/or hypertension medication in the last 30 days
Trial design
Treatments tested in this trial
- Controlled dietary intervention
Treatment groups
Locations
1Sponsors and collaborators
Indiana University
Lead sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator